About Us

Company Overview

Cardiol Therapeutics is a leader in producing the purest pharmaceutical CBD products and developing innovative therapies for heart disease.


Cardiol brings together a wealth of research and development experience, advanced manufacturing capabilities, and a management team, Board of Directors, and Scientific Advisory Board comprising business and thought leaders with extensive industry experience and expertise in commercializing proprietary drugs.

We are leveraging our expertise in pharmaceutical cannabinoids to develop proprietary formulations for commercial development in two important medical markets: commercializing a line of pharmaceutical CBD products in the growing market for medical cannabinoids and developing nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs to the heart for the treatment of inflammatory heart disease.